Cite
Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13.
MLA
Kim, Yeoun-Hee, et al. “Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13.” PLoS ONE, vol. 12, no. 1, Jan. 2017, pp. 1–24. EBSCOhost, https://doi.org/10.1371/journal.pone.0169675.
APA
Kim, Y.-H., Jung, J.-C., Gum, S. I., Park, S.-B., Ma, J. Y., Kim, Y. I., Lee, K. W., & Park, Y. J. (2017). Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13. PLoS ONE, 12(1), 1–24. https://doi.org/10.1371/journal.pone.0169675
Chicago
Kim, Yeoun-Hee, Jae-Chang Jung, Sang Il Gum, Su-Bin Park, Jin Yeul Ma, Yong Il Kim, Kyoo Won Lee, and Young Jeung Park. 2017. “Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13.” PLoS ONE 12 (1): 1–24. doi:10.1371/journal.pone.0169675.